Conformal Medical Announces Launch of CONFORM Pivotal Trial
- Friday, June 17, 2022, 7:11
- PR Newswire
- Add a comment
Study to support U.S. FDA approval of the novel CLAAS® implant for left atrial appendage occlusion (LAAO) and stroke prevention NASHUA, N.H., June 17, 2022 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation LAAO technology, today announced the…